Literature DB >> 12126753

Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease.

Kevin P Pavlick1, F Stephen Laroux, John Fuseler, Robert E Wolf, Laura Gray, Jason Hoffman, Matthew B Grisham.   

Abstract

The inflammatory bowel diseases (IBD; Crohn's disease, ulcerative colitis) are a collection of chronic idiopathic inflammatory disorders of the intestine and/or colon. Although the pathophysiology of IBD is not known with certainty, a growing body of experimental and clinical data suggests that chronic gut inflammation may result from a dysregulated immune response to normal bacterial antigens. This uncontrolled immune system activation results in the sustained overproduction of reactive metabolites of oxygen and nitrogen. It is thought that some of the intestinal and/or colonic injury and dysfunction observed in IBD is due to elaboration of these reactive species. This review summarizes the current state-of-knowledge of the role of reactive oxygen species and nitric oxide in the pathophysiology of IBD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126753     DOI: 10.1016/s0891-5849(02)00853-5

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  113 in total

Review 1.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

2.  Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn's disease.

Authors:  Kazunari Yamamoto; Toshimi Chiba; Takayuki Matsumoto
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

3.  Stimulation of colonic anion secretion by monochloramine: action sites.

Authors:  Gerhard Schultheiss; Sarah Lán Kocks; Martin Diener
Journal:  Pflugers Arch       Date:  2004-12-23       Impact factor: 3.657

4.  The effect of neighboring methionine residue on tyrosine nitration and oxidation in peptides treated with MPO, H2O2, and NO2(-) or peroxynitrite and bicarbonate: role of intramolecular electron transfer mechanism?

Authors:  Hao Zhang; Jacek Zielonka; Adam Sikora; Joy Joseph; Yingkai Xu; B Kalyanaraman
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

Review 5.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

6.  Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats.

Authors:  Arturo L Colón; José L M Madrigal; Luis A Menchén; María A Moro; Ignacio Lizasoain; Pedro Lorenzo; Juan C Leza
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

7.  Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress.

Authors:  Carlos Felipe Bernardes-Silva; Adérson O M C Damião; Aytan M Sipahi; Francisco R M Laurindo; Kiyoshi Iriya; Fabio P Lopasso; Carlos A Buchpiguel; Maria Laura L Lordello; Carmem L O Agostinho; Antonio A Laudanna
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes.

Authors:  Tareq Taha Jubeh; Yechezkel Barenholz; Abraham Rubinstein
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

9.  Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

Authors:  Shao-Ping Liu; Wei-Guo Dong; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD.

Authors:  Alberto J León; Emma Gómez; Jose A Garrote; David Bernardo; Asterio Barrera; Jose L Marcos; Luis Fernández-Salazar; Benito Velayos; Alfredo Blanco-Quirós; Eduardo Arranz
Journal:  Mediators Inflamm       Date:  2009-07-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.